SQDHD may exert neuroprotective effects in NPSLE by inhibiting the activation of CVECs through blocking the JAK1-STAT3 signaling pathway, thereby suggesting its potential as a promising therapeutic strategy for NPSLE.
Chen et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: